Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension
Authors
Keywords
-
Journal
OSTEOPOROSIS INTERNATIONAL
Volume 23, Issue 6, Pages 1769-1778
Publisher
Springer Nature
Online
2011-10-05
DOI
10.1007/s00198-011-1793-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bisphosphonate-associated adverse events
- (2014) Peter Papapetrou Hormones-International Journal of Endocrinology and Metabolism
- Atypical fractures and bisphosphonate therapy: A cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features
- (2011) Andrea Giusti et al. BONE
- Atypical fractures of the femur and bisphosphonate therapy
- (2010) Andrea Giusti et al. BONE
- Long-Term Use of Bisphosphonates in Osteoporosis
- (2010) Nelson B. Watts et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone turnover markers in the management of postmenopausal osteoporosis
- (2009) Jacques P. Brown et al. CLINICAL BIOCHEMISTRY
- Unusual mid-shaft fractures during long-term bisphosphonate therapy
- (2009) Clarita V. Odvina et al. CLINICAL ENDOCRINOLOGY
- Case Reports: Two Femoral Insufficiency Fractures after Long-term Alendronate Therapy
- (2009) Arkan S. Sayed-Noor et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Low-Energy Femoral Fractures Associated with the Long-Term Use of Bisphosphonates
- (2009) Kuntheavy Ing-Lorenzini et al. DRUG SAFETY
- Bisphosphonates for postmenopausal osteoporosis: Determining duration of treatment
- (2009) Piet Geusens Current Osteoporosis Reports
- Ibandronate dose response is associated with increases in bone mineral density and reductions in clinical fractures: Results of a meta-analysis
- (2008) Anthony I. Sebba et al. BONE
- Osteonecrosis of the jaw — Who gets it, and why?
- (2008) Ian R. Reid BONE
- Insight into bisphosphonate-associated osteomyelitis of the jaw: pathophysiology, mechanisms and clinical management
- (2008) Sunil J Wimalawansa Expert Opinion On Drug Safety
- An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?
- (2008) Ernest Beng Kee Kwek et al. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
- Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II)
- (2008) Peyman Hadji et al. JOINT BONE SPINE
- Low-Energy Femoral Shaft Fractures Associated With Alendronate Use
- (2008) Andrew S Neviaser et al. JOURNAL OF ORTHOPAEDIC TRAUMA
- Atypical Fractures of the Femoral Diaphysis in Postmenopausal Women Taking Alendronate
- (2008) Brett A. Lenart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data
- (2008) A. Cranney et al. OSTEOPOROSIS INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now